NO136251C - Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater. - Google Patents

Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.

Info

Publication number
NO136251C
NO136251C NO1533/72A NO153372A NO136251C NO 136251 C NO136251 C NO 136251C NO 1533/72 A NO1533/72 A NO 1533/72A NO 153372 A NO153372 A NO 153372A NO 136251 C NO136251 C NO 136251C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
pyridazine derivatives
analogical procedure
active pyridazine
Prior art date
Application number
NO1533/72A
Other languages
English (en)
Other versions
NO136251B (no
Inventor
Erhard Schenker
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH695171A external-priority patent/CH547807A/de
Priority claimed from CH695271A external-priority patent/CH547808A/de
Priority claimed from CH767971A external-priority patent/CH547813A/de
Priority claimed from CH768371A external-priority patent/CH547814A/de
Priority claimed from CH784871A external-priority patent/CH551433A/de
Priority claimed from CH784971A external-priority patent/CH553201A/de
Priority claimed from CH1512071A external-priority patent/CH555350A/de
Priority claimed from CH1512171A external-priority patent/CH555841A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO136251B publication Critical patent/NO136251B/no
Publication of NO136251C publication Critical patent/NO136251C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO1533/72A 1971-05-11 1972-05-02 Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater. NO136251C (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH695171A CH547807A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH695271A CH547808A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH767971A CH547813A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH768371A CH547814A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH784871A CH551433A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer 3-hydrazino-5,6,7,8-tetrahydropyrido (4,3-c)pyridazin-derivate.
CH784971A CH553201A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazinderivate.
CH1512071A CH555350A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido(4,3c)-pyridazine.
CH1512171A CH555841A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido-(4,3c)pyridazine.

Publications (2)

Publication Number Publication Date
NO136251B NO136251B (no) 1977-05-02
NO136251C true NO136251C (no) 1977-08-10

Family

ID=27570368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1533/72A NO136251C (no) 1971-05-11 1972-05-02 Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.

Country Status (16)

Country Link
US (2) US3838125A (no)
JP (1) JPS5750791B1 (no)
AU (1) AU472726B2 (no)
BE (1) BE783219A (no)
CA (1) CA943542A (no)
DD (1) DD97418A5 (no)
DK (1) DK139625B (no)
FI (1) FI55343C (no)
GB (2) GB1392474A (no)
HU (1) HU168682B (no)
IE (1) IE36710B1 (no)
IL (1) IL39392A (no)
NL (1) NL176565C (no)
NO (1) NO136251C (no)
PL (1) PL81827B1 (no)
SE (1) SE400557B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139625B (da) * 1971-05-11 1979-03-19 Sandoz Ag Analogifremgangsmåde til fremstilling af cycloalkan(c)pyridazin- eller pyrido(4,3-c)pyridazinderivater eller syreadditionssalte deraf.
DK397774A (no) * 1973-08-02 1975-04-01 Sandoz Ag
SE418800B (sv) * 1975-11-13 1981-06-29 Sandoz Ag Forfarande for framstellning av nya antihypertensiva preparat
US4277472A (en) * 1978-11-10 1981-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh 3,6-Disubstituted-5,7-(lower alkano)-5,6,7,8-tetrahydropyrido(4,3-C)pyridazines; their intermediates, preparation, antihypertensive use and compositions
US4473574A (en) * 1982-02-01 1984-09-25 Sandoz Ltd. Prophylaxis of arterial disease
US6176240B1 (en) 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6821974B2 (en) * 2002-03-05 2004-11-23 Barbeau Pharma, Inc Stable pharmaceutical compositions
US6825196B2 (en) * 2002-03-05 2004-11-30 Barbeau Pharma, Inc. Stable pharmaceutical compositions
CN102911173A (zh) * 2012-11-08 2013-02-06 苏州施亚生物科技有限公司 5,6,7,8-四氢-2H-吡啶并[4,3-c]哒嗪-3-酮的合成方法
CN106905315B (zh) * 2017-03-02 2019-09-27 北京工业大学 四氢吡啶并[3,4-d]嘧啶类化合物及其制备方法和应用
WO2020012916A1 (ja) 2018-07-10 2020-01-16 国立研究開発法人産業技術総合研究所 積層構造体及びその製造方法並びに半導体デバイス

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139625B (da) * 1971-05-11 1979-03-19 Sandoz Ag Analogifremgangsmåde til fremstilling af cycloalkan(c)pyridazin- eller pyrido(4,3-c)pyridazinderivater eller syreadditionssalte deraf.

Also Published As

Publication number Publication date
AU4213572A (en) 1973-11-15
GB1392475A (en) 1975-04-30
DK139625C (no) 1979-09-03
IE36710L (en) 1972-11-11
NO136251B (no) 1977-05-02
AU472726B2 (en) 1976-06-03
PL81827B1 (no) 1975-10-31
NL176565C (nl) 1985-05-01
SE400557B (sv) 1978-04-03
BE783219A (fr) 1972-11-09
CA943542A (en) 1974-03-12
GB1392474A (en) 1975-04-30
IL39392A (en) 1977-10-31
DK139625B (da) 1979-03-19
NL176565B (nl) 1984-12-03
FI55343C (fi) 1979-07-10
DD97418A5 (no) 1973-05-05
NL7206477A (no) 1972-11-14
IL39392A0 (en) 1972-07-26
US3838125A (en) 1974-09-24
IE36710B1 (en) 1977-02-02
HU168682B (no) 1976-06-28
FI55343B (fi) 1979-03-30
US4478837A (en) 1984-10-23
JPS5750791B1 (no) 1982-10-28

Similar Documents

Publication Publication Date Title
NO136837C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner
NO138805C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
NO140301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner
NO136793C (no) Analogifremgangsm}te til fremstilling av terapeutisk virksomme substituerte 1,2,4-triazolderivater.
NO136298C (no) Analogifremgangsm}te til fremstilling av antibakterielt virksomme imidazolderivater
NO136045C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazinoner.
NO136094C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater.
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO136251C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO773495L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylalkylaminer
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO136574C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater.
NO136926C (no) Analogifremgangsm}te til fremstilling av terapeutisk aktive papaverinanaloger
NO136795C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO137696C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepin-derivater
NO136841C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO136198C (no) Analogifremgangsm}te ved fremstilling av terapeutisk aktivt 16-carboxy-17-methoxy-eburnan.
NO136977C (no) Analogifremgangsm}te for mstilling av terapeutisk aktive oksazolidiner